Article
PRAME Epitopes are T-Cell Immunovulnerabilities in BRD4::NUTM1 Initiated NUT Carcinoma
medRxiv · 2025 · Jensen, J. L.; Peterson, S. K.; Yu, S.; Kinjo, T.; Price, B. A.; Sambade, M.; Vesko, S.; DeBetta, J. D.; Geyer, J. K.; Nickel, K. P.; Kimple, R. J.; Kotecha, R. S.; Davis, I. J.; Wang, J. R.; French, C. A.; Kuhlman, B.; Rubinsteyn, A.; Weiss, J.; Vincent, B. G.
Key facts
| Title | PRAME Epitopes are T-Cell Immunovulnerabilities in BRD4::NUTM1 Initiated NUT Carcinoma |
|---|---|
| First author | Jensen, J. L.; Peterson, S. K.; Yu, S.; Kinjo, T.; Price, B. A.; Sambade, M.; Vesko, S.; DeBetta, J. D.; Geyer, J. K.; Nickel, K. P.; Kimple, R. J.; Kotecha, R. S.; Davis, I. J.; Wang, J. R.; French, C. A.; Kuhlman, B.; Rubinsteyn, A.; Weiss, J.; Vincent, B. G. |
| Journal | medRxiv |
| Published | Jan 1, 2025 |
| DOI | 10.1101/2025.03.07.642090 |
| Product codes mentioned | JCC, JJH, MVU, NJT, PFF, PFT, PPM |
At a glance
- None FDA submissions mentioned
- 1–9 Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1